Enanta Pharmaceuticals reported $207K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Amgen AMGN:US $ 31343M 96M
Anika Therapeutics ANIK:US $ 0.15M 0M
Arrowhead Research ARWR:US $ 198K 0
AstraZeneca AZN:LN 387M 0M
Biogen BIIB:US $ 0.1M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Clovis Oncology CLVS:US $ 0.14M 0M
Enanta Pharmaceuticals ENTA:US $ 0.21M 0M
GlaxoSmithKline GSK:LN 134700M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Insmed INSM:US $ 1.2M 6K
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 890M 11M
Novavax NVAX:US $ 0.79M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M
Vital Therapies VTL:US $ 0M 0M
YTE INCY:US $ 0.22M 0M